Phibro Animal Health Corporation Reports Third Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Trump says Canada's Bombardier must build jets in US or lose market access
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Guggenheim Cuts Price Target on Phibro Animal Health (PAHC) Following 3Q Miss
May 10, 2016 2:06 PM EDTGuggenheim maintained a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and cut the price target to $26.00 (from $34.00), following the company's 3Q earnings report. PAHC reported F'3Q16 EPS of $0.38, $0.03 lower than consensus. PAHC lowered its F'16 revenue and EPS guidance to $745MM-$750MM, and... More
Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
May 9, 2016 4:19 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.38, $0.05 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $183 million versus the consensus estimate of $197.24 million.
GUIDANCE:
Phibro Animal Health sees FY2016 EPS of $1.58-$1.60, versus the... More
